MedAid
Accessible medication tracker
About
This app provides gentle reminders and a clear interface to help you take your medications on time. It offers trusted medication information and is designed with accessibility in mind for all users.
What's New in MedAid
1.1
January 15, 2026
• Improved VoiceOver accessibility for date pickers • New dosage units • Improved drug database support . Auto medication database updates (iOS 26+) • Bug fixes and performance improvements
MoreEvents
FAQ
What is MedAid?
MedAid is a free medication tracking and reminder tool designed to help users take their pills on time. It provides gentle reminders and offers official medication information to build consistent daily habits.
Is MedAid free to use?
Yes, MedAid is completely free to download and use. There are no in-app purchases or subscription fees associated with its core functionality.
Does MedAid have ads?
No, MedAid is ad-free. The app is designed to provide a seamless and uninterrupted experience for users managing their medications.
What devices does MedAid support?
Currently, MedAid is supported on iPhone devices. The app is designed to be accessible across various iOS versions.
How often is MedAid updated?
The latest version of MedAid is 1.1, which was last updated on January 15, 2026. Updates typically focus on improving functionality and user experience.
What is the age rating for MedAid?
MedAid has an age rating of 12+, making it suitable for teenagers and adults. This rating reflects the content and functionality of the medication tracking tool.
Can MedAid replace professional medical advice?
No, MedAid is strictly a medication tracking and reminder tool. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a healthcare provider for medical concerns.
What makes MedAid accessible?
MedAid is built with accessibility in mind, featuring VoiceOver-friendly navigation, adjustable text sizes using Dynamic Type, clear layouts, and high-contrast elements to ensure ease of use for everyone.